Literature DB >> 30626754

Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.

Jeremy Herrera1, Colleen Forster2, Thomas Pengo3, Angeles Montero4, Joe Swift1, Martin A Schwartz1, Craig A Henke5, Peter B Bitterman5.   

Abstract

The extracellular matrix (ECM) in idiopathic pulmonary fibrosis (IPF) drives fibrosis progression; however, the ECM composition of the fibroblastic focus (the hallmark lesion in IPF) and adjacent regions remains incompletely defined. Herein, we serially sectioned IPF lung specimens constructed into tissue microarrays and immunostained for ECM components reported to be deregulated in IPF. Immunostained sections were imaged, anatomically aligned, and 3D reconstructed. The myofibroblast core of the fibroblastic focus (defined by collagen I, α-smooth muscle actin, and procollagen I immunoreactivity) was associated with collagens III, IV, V, and VI; fibronectin; hyaluronan; and versican immunoreactivity. Hyaluronan immunoreactivity was also present at the fibroblastic focus perimeter and at sites where early lesions appear to be forming. Fibrinogen immunoreactivity was often observed at regions of damaged epithelium lining the airspace and the perimeter of the myofibroblast core but was absent from the myofibroblast core itself. The ECM components of the fibroblastic focus were distributed in a characteristic and reproducible manner in multiple patients. This information can inform the development of high-fidelity model systems to dissect mechanisms by which the IPF ECM drives fibrosis progression.

Entities:  

Keywords:  Fibrosis; Pulmonology

Year:  2019        PMID: 30626754      PMCID: PMC6485370          DOI: 10.1172/jci.insight.125185

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  44 in total

1.  Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis.

Authors:  Masahito Ebina; Minoru Shimizukawa; Naoko Shibata; Yuichiro Kimura; Takashi Suzuki; Mareyuki Endo; Hironobu Sasano; Takashi Kondo; Toshihiro Nukiwa
Journal:  Am J Respir Crit Care Med       Date:  2004-01-30       Impact factor: 21.405

2.  Interstitial and vascular type V collagen morphologic disorganization in usual interstitial pneumonia.

Authors:  Edwin Roger Parra; Walcy R Teodoro; Ana Paula Pereira Velosa; Cristiane Carla de Oliveira; Natalino Hajime Yoshinari; Vera Luiza Capelozzi
Journal:  J Histochem Cytochem       Date:  2006-08-21       Impact factor: 2.479

3.  Proliferative activity in fibrosing lung diseases: a comparative study of Ki-67 immunoreactivity in diffuse alveolar damage, bronchiolitis obliterans-organizing pneumonia, and usual interstitial pneumonia.

Authors:  Ola El-Zammar; Paula Rosenbaum; Anna-Luise A Katzenstein
Journal:  Hum Pathol       Date:  2009-04-14       Impact factor: 3.466

4.  The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix.

Authors:  Hui Zhu; Noboru Mitsuhashi; Andrew Klein; Lora W Barsky; Kenneth Weinberg; Mark L Barr; Achilles Demetriou; Gordon D Wu
Journal:  Stem Cells       Date:  2005-11-23       Impact factor: 6.277

5.  Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis.

Authors:  James S Hagood; Priya Prabhakaran; Pallavi Kumbla; Lorena Salazar; Mark W MacEwen; Thomas H Barker; Luis A Ortiz; Trenton Schoeb; Gene P Siegal; C Bruce Alexander; Annie Pardo; Moisés Selman
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

6.  In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin.

Authors:  Frank Wang; Luis A Garza; Sewon Kang; James Varani; Jeffrey S Orringer; Gary J Fisher; John J Voorhees
Journal:  Arch Dermatol       Date:  2007-02

Review 7.  Random versus directionally persistent cell migration.

Authors:  Ryan J Petrie; Andrew D Doyle; Kenneth M Yamada
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07-15       Impact factor: 94.444

8.  Serum inter-alpha-trypsin inhibitor and matrix hyaluronan promote angiogenesis in fibrotic lung injury.

Authors:  Stavros Garantziotis; Enrique Zudaire; Carol S Trempus; John W Hollingsworth; Dianhua Jiang; Lisa H Lancaster; Elizabeth Richardson; Lisheng Zhuo; Frank Cuttitta; Kevin K Brown; Paul W Noble; Koji Kimata; David A Schwartz
Journal:  Am J Respir Crit Care Med       Date:  2008-08-14       Impact factor: 21.405

9.  Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis.

Authors:  T J Broekelmann; A H Limper; T V Colby; J A McDonald
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

Review 10.  Integrins: roles in cancer development and as treatment targets.

Authors:  H Jin; J Varner
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

View more
  12 in total

Review 1.  Defining the versican interactome in lung health and disease.

Authors:  Fengying Tang; Jourdan E Brune; Mary Y Chang; Stephen R Reeves; William A Altemeier; Charles W Frevert
Journal:  Am J Physiol Cell Physiol       Date:  2022-06-01       Impact factor: 5.282

Review 2.  Biomechanical Force and Cellular Stiffness in Lung Fibrosis.

Authors:  Richard S Nho; Megan N Ballinger; Mauricio M Rojas; Samir N Ghadiali; Jeffrey C Horowitz
Journal:  Am J Pathol       Date:  2022-02-17       Impact factor: 5.770

Review 3.  From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?

Authors:  Jacob E Michalski; Jonathan S Kurche; David A Schwartz
Journal:  Transl Res       Date:  2021-09-20       Impact factor: 10.171

4.  Translocation of TRPV4-PI3Kγ complexes to the plasma membrane drives myofibroblast transdifferentiation.

Authors:  Lisa M Grove; Maradumane L Mohan; Susamma Abraham; Rachel G Scheraga; Brian D Southern; James F Crish; Sathyamangla V Naga Prasad; Mitchell A Olman
Journal:  Sci Signal       Date:  2019-11-12       Impact factor: 8.192

5.  A CD44/Brg1 nuclear complex confers mesenchymal progenitor cells with enhanced fibrogenicity in idiopathic pulmonary fibrosis.

Authors:  Libang Yang; Hong Xia; Karen Smith; Adam Gilbertsen; Daniel Beisang; Jonathan Kuo; Peter B Bitterman; Craig A Henke
Journal:  JCI Insight       Date:  2021-05-10

6.  A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages.

Authors:  Nikita Joshi; Satoshi Watanabe; Rohan Verma; Renea P Jablonski; Ching-I Chen; Paul Cheresh; Nikolay S Markov; Paul A Reyfman; Alexandra C McQuattie-Pimentel; Lango Sichizya; Ziyan Lu; Raul Piseaux-Aillon; David Kirchenbuechler; Annette S Flozak; Cara J Gottardi; Carla M Cuda; Harris Perlman; Manu Jain; David W Kamp; G R Scott Budinger; Alexander V Misharin
Journal:  Eur Respir J       Date:  2020-01-16       Impact factor: 16.671

7.  Laser capture microdissection coupled mass spectrometry (LCM-MS) for spatially resolved analysis of formalin-fixed and stained human lung tissues.

Authors:  Jeremy A Herrera; Venkatesh Mallikarjun; Silvia Rosini; Maria Angeles Montero; Craig Lawless; Stacey Warwood; Ronan O'Cualain; David Knight; Martin A Schwartz; Joe Swift
Journal:  Clin Proteomics       Date:  2020-06-17       Impact factor: 3.988

8.  An integrated multiomic and quantitative label-free microscopy-based approach to study pro-fibrotic signalling in ex vivo human precision-cut lung slices.

Authors:  Muzamil Majid Khan; Daniel Poeckel; Aliaksandr Halavatyi; Joanna Zukowska-Kasprzyk; Frank Stein; Johanna Vappiani; Daniel C Sevin; Christian Tischer; Nico Zinn; Jessica D Eley; Natasja Stæhr Gudmann; Thomas Muley; Hauke Winter; Andrew J Fisher; Carmel B Nanthakumar; Giovanna Bergamini; Rainer Pepperkok
Journal:  Eur Respir J       Date:  2021-07-01       Impact factor: 16.671

9.  The UIP/IPF fibroblastic focus is a collagen biosynthesis factory embedded in a distinct extracellular matrix.

Authors:  Jeremy A Herrera; Lewis Dingle; M Angeles Montero; Rajamiyer V Venkateswaran; John F Blaikley; Craig Lawless; Martin A Schwartz
Journal:  JCI Insight       Date:  2022-08-22

10.  Distal Lung Microenvironment Triggers Release of Mediators Recognized as Potential Systemic Biomarkers for Idiopathic Pulmonary Fibrosis.

Authors:  Dimitrios Kalafatis; Anna Löfdahl; Per Näsman; Göran Dellgren; Åsa M Wheelock; Linda Elowsson Rendin; Magnus Sköld; Gunilla Westergren-Thorsson
Journal:  Int J Mol Sci       Date:  2021-12-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.